首页> 美国卫生研究院文献>Bulletin of the New York Academy of Medicine >Incidence and Risk Factors for Hepatitis C Virus Infection among Illicit Drug Users in Italy
【2h】

Incidence and Risk Factors for Hepatitis C Virus Infection among Illicit Drug Users in Italy

机译:意大利非法吸毒者中丙型肝炎病毒感染的发生率和危险因素

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

So far, only three small outdated studies have investigated hepatitis C virus (HCV) incidence and risk factors among illicit drug users (DUs) in Italy. Thus, during 2007–2010, we conducted a prospective cohort study among DUs attending 17 Italian rehabilitation centers serving urban areas. Two hundred eighty-four HCV-uninfected DUs were prospectively followed by interview and anti-HCV antibody and RNA testing every 6 months. Incidence was calculated using the person-years method. Infection predictors were assessed by time-dependent Cox analysis. Participants were mostly male (83.4%), under opioid substitution therapy (OST) (78.9%), non-injecting DUs (67.9%), and with a mean age of 30.8. Ninety-one of 224 DUs initially under OST interrupted treatment during the follow-up. Overall HCV incidence was 5.83/100 person-years at risk (PYAR) [95% confidence intervals (CI), 3.63–9.38]. The incidence did not significantly differ according the participants’ sociodemographic characteristics or the degree of urbanization of the towns involved in the study. The incidence was higher for DUs under than for those not under OST (6.23 vs 4.50/100 PYAR; p = 0.681). Incidence was also higher for those with than for those without OST interruption (7.17 vs 5.04/100 PYAR; p = 0.55). However, all these differences were non-significant. At last follow-up visit, a significant decrease in frequency of sharing equipment for preparation/using drugs (by injection or not) was observed by analyzing either the whole cohort or DUs under OST only. Anti-HCV seroconversion resulted independently associated with sharing drug preparation/use equipment, backloading, having a HCV-positive sexual partner, or household and (marginally) intravenous injection. In this study, HCV incidence was non-negligible and OST seemed to lack effectiveness in reducing it. In Italy, implementation of combined harm reduction interventions and antiviral treatment of chronically infected DUs would be needed.
机译:到目前为止,只有三项过时的小型研究调查了意大利非法药物使用者(DUs)中的丙型肝炎病毒(HCV)发病率和危险因素。因此,在2007年至2010年期间,我们对参加服务于城市地区的17个意大利康复中心的DU进行了前瞻性队列研究。每6个月对284个未感染HCV的DU进行前瞻性采访,抗HCV抗体和RNA检测。使用人年法计算发病率。通过时间依赖性Cox分析评估感染预测因子。参与者主要是男性(83.4%),接受阿片类药物替代疗法(OST)(78.9%),非注射用药单位(67.9%),平均年龄为30.8岁。最初接受OST治疗的224个DU中有91个在随访期间中断了治疗。总体HCV发生率为5.83 / 100人年危险(PYAR)[95%置信区间(CI),3.63–9.38]。根据参与者的社会人口统计学特征或参与研究的城镇的城市化程度,发病率没有显着差异。低于OST的DU的发生率高于未低于OST的DU(6.23 vs 4.50 / 100 PYAR; p = 0.681)。有OST的患者的发病率也高于没有OST中断的患者(7.17 vs 5.04 / 100 PYAR; p = 0.55)。但是,所有这些差异都不重要。在最后一次随访中,仅通过OST分析整个队列或DU,观察到共享用于制备/使用药物(无论是否注射)的设备的频率显着下降。抗HCV血清转化的结果独立于共用药物准备/使用设备,背负负荷,具有HCV阳性性伴侣或家庭和(少量)静脉注射。在这项研究中,HCV的发生率不可忽略,并且OST似乎缺乏降低它的效果。在意大利,将需要实施减少伤害的干预措施和对慢性感染的DUs进行抗病毒治疗的结合。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号